Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC

Clinical trial NCT07359404 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07359404
Sponsor: YING FAN
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2024-04-01
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.